{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:56:48Z","timestamp":1790791008024,"version":"4.1.0"},"reference-count":31,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":103,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Biopharm &amp;amp; Drug Disp"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Doxorubicin hydrochloride liposome injection represents a complex nano\u2010drug delivery system with significant clinical advantages, yet its quality evaluation remains challenging. Traditional static release methods often fail to simulate the physiological environment, which leads to poor in vivo predictions. The flow\u2010through cell method provides distinct advantages by simulating hemodynamic characteristics and maintaining stable sink conditions. This study utilizes the flow\u2010through cell method to simulate the release process of doxorubicin hydrochloride liposomes and establishes a Level A in vitro\u2010in vivo correlation (IVIVC) based on the in vivo data of three commercial brands to develop a biorelevant in vitro release method. The in vivo cumulative release fraction is derived from the plasma concentration data of three commercial products using the fractional area (AUC) method for deconvolution, which serves as the target reference for the in vitro release profile. In vitro release experiments are conducted using a phosphate buffer containing 0.3% SDS and 15% artificial plasma as the release medium, which is optimized through single\u2010factor analysis and an\n                    <jats:italic>L<\/jats:italic>\n                    <jats:sub>9<\/jats:sub>\n                    (3\n                    <jats:sup>4<\/jats:sup>\n                    ) orthogonal experimental design. The experimental setup employs a dialysis membrane with a 300\u00a0KDa molecular weight cutoff and a flow rate of 4\u00a0mL\/min. High\u2010performance liquid chromatography (HPLC) determines the concentration of the released drug to calculate the in vitro cumulative release fraction. A Level A IVIVC model is established between the cumulative in vitro and in vivo release fractions of doxorubicin hydrochloride liposome injection, which is subsequently confirmed through internal validation. The IVIVC model demonstrates robust predictive capability, and the developed in vitro release method exhibits high sensitivity in distinguishing the release characteristics of products from different manufacturers. This study provides a scientific reference for the in vitro\u2010in vivo correlation and quality evaluation of long\u2010acting injections.\n                  <\/jats:p>","DOI":"10.1002\/bdd.70036","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T10:02:56Z","timestamp":1789207376000},"page":"138-149","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a Biorelevant In Vitro Release System and Level A In Vitro\u2010In Vivo Correlation for Doxorubicin Hydrochloride Liposome Injection via Flow\u2010Through Cell Method"],"prefix":"10.1002","volume":"47","author":[{"given":"Xue\u2010ting","family":"Huang","sequence":"first","affiliation":[{"name":"College of Pharmacy and International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education Jinan University  Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing\u2010jing","family":"Liu","sequence":"additional","affiliation":[{"name":"Shenzhen Institute for Drug Control  Shenzhen China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3652-0924","authenticated-orcid":false,"given":"Xi\u2010yang","family":"Tang","sequence":"additional","affiliation":[{"name":"College of Pharmacy and International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education Jinan University  Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Yin","sequence":"additional","affiliation":[{"name":"Shenzhen Institute for Drug Control  Shenzhen China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Dai","sequence":"additional","affiliation":[{"name":"College of Pharmacy and International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education Jinan University  Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4333-2157","authenticated-orcid":false,"given":"Xiao\u2010wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Shenzhen Institute for Drug Control  Shenzhen China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rsurfi.2025.100473"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030893"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2019.10.014"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122642"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17101310"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2018.09.017"},{"key":"e_1_2_9_8_1","volume-title":"Guidance for Industry: Extended Release Oral Dosage Forms Development Evaluation and Application of In Vitro In Vivo Correlations","author":"FDA","year":"1997"},{"key":"e_1_2_9_9_1","unstructured":"FDA.2018.Guidance for Industry: Bioanalytical Method Validation."},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249\u2010017\u20100842\u2010x"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248\u2010020\u201000445\u20100"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.2478\/acph\u20102020\u20100030"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1732"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.104112"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.03.025"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40005\u2010023\u201000655\u20106"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12010036"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.120051"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10030130"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114906"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13050690"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpolymj.2019.109366"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.05.002"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfa.2025.138318"},{"key":"e_1_2_9_25_1","unstructured":"U.S. Food and Drug Administration.2022.Drug Products Including Biological Products that Contain Nanomaterials; Guidance for Industry.https:\/\/www.fda.gov\/regulatory\u2010information\/search\u2010fda\u2010guidance\u2010documents\/drug\u2010products\u2010including\u2010biological\u2010products\u2010contain\u2010nanomaterials\u2010guidance\u2010industry."},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/ma14030555"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.11.021"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.langmuir.4c03322"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248\u2010016\u20109958\u20102"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2023.11.035"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.langmuir.9b00572"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.08.001"}],"container-title":["Biopharmaceutics &amp; Drug Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bdd.70036","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/bdd.70036","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bdd.70036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:10:12Z","timestamp":1790788212000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/bdd.70036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1002\/bdd.70036"],"URL":"https:\/\/doi.org\/10.1002\/bdd.70036","archive":["Portico"],"relation":{},"ISSN":["0142-2782","1099-081X"],"issn-type":[{"value":"0142-2782","type":"print"},{"value":"1099-081X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"2026-05-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}